Mark Pulse Selected Research

Mark Pulse Research Topics

5	Clostridium Infections 10/2021 - 10/2014
4	Infections 12/2019 - 08/2011
2	Dysbiosis 12/2019 - 10/2018
2	Sepsis (Septicemia) 08/2011 - 05/2008
1	Bacterial Infections (Bacterial Infection) 01/2022
1	Diarrhea 12/2019
1	Colitis 10/2017
1	Body Weight (Weight, Body) 10/2014
1	Mycoplasma Pneumonia 08/2014
1	Pneumonia (Pneumonitis) 08/2014
1	Granuloma 05/2013
1	Pneumococcal Infections 08/2011

4	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 10/2014
3	Charcoal (Charbon)IBA 12/2019 - 10/2017
2	Moxifloxacin (Avelox)FDA Link 10/2018 - 10/2017
2	Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)IBA 08/2011 - 05/2008
1	RifamycinsIBA 01/2022
1	NitroimidazolesIBA 01/2022
1	Secretory Immunoglobulin A (SIgA)IBA 10/2021
1	Vancomycin FDA LinkGeneric 10/2021
1	Levofloxacin (Levaquin)FDA Link 12/2019
1	Ciprofloxacin (Cipro)FDA LinkGeneric 12/2019
1	FluoroquinolonesIBA 12/2019
1	Clindamycin (Cleocin)FDA LinkGeneric 10/2018
1	16S Ribosomal RNAIBA 10/2018
1	ridinilazoleIBA 10/2014
1	VaccinesIBA 08/2014
1	AntigensIBA 08/2014
1	API 1252IBA 05/2013
1	Corticotropin-Releasing HormoneIBA 08/2011
1	CRF receptor type 2IBA 08/2011

1	Immunotherapy 10/2021